Upcoming Studies

Atopic Dermatitis

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Trial to Evaluate the Efficacy and Safety of ASLAN004 in Adult Patients with Moderate-to-Severe Atopic Dermatitis (ASLAN)

Study Contact: Madeleine Smee
https://clinicaltrials.gov/ct2/show/NCT04090229

Hereditary Angioedema

A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE) (KVD900-301)

Study Contact: Leena Johnson Chacko
https://www.clinicaltrials.gov/ct2/show/NCT05259917